{"id":"W4361954214","doi":"10.1158/1078-0432.c.6532491.v1","title":"Data from Putative Biomarkers of Clinical Benefit With Pembrolizumab in Advanced Urothelial Cancer: Results from the KEYNOTE-045 and KEYNOTE-052 Landmark Trials","year":2023,"lang":"en","type":"preprint","venue":"","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"","keywords":"Pembrolizumab; Medicine; Docetaxel; Oncology; Internal medicine; Stromal cell; Clinical trial; Chemotherapy; Progression-free survival; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01206269,0.001143484,0.002836257,0.0004609658,0.0004041527,0.002263914,0.001007313,0.001346865,0.004112145],"category_scores_gemma":[0.01512606,0.0003827244,0.004866429,0.001300837,0.0006245974,0.002161711,0.0009116247,0.002635153,0.0007736695],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009773439,"about_ca_system_score_gemma":0.0012045,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005342858,"about_ca_topic_score_gemma":0.00153521,"domain_scores_codex":[0.9937755,0.00395978,0.0006049277,0.000662818,0.0006917542,0.0003053107],"domain_scores_gemma":[0.9858978,0.006393651,0.004121286,0.001661725,0.0009639603,0.0009616688],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6885687,0.001710064,0.06495006,0.01170915,0.04216017,0.0002443806,0.0002787796,0.005498772,0.00797806,0.001757824,0.02211558,0.1530285],"study_design_scores_gemma":[0.2847345,0.1001605,0.4393573,0.003653307,0.06902359,0.001009855,0.0003652888,0.004810529,0.007526382,0.00640054,0.08262574,0.0003324885],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"dataset","genre_scores_codex":[0.7518534,0.1665916,0.005158908,0.007930173,0.0009839856,0.002473438,0.04916681,0.0003274679,0.01551425],"genre_scores_gemma":[0.962727,0.009659531,0.001931617,0.002731512,0.000473461,0.001609297,0.0191457,0.00006635726,0.001655584],"genre_candidate":"dataset","genre_consensus":null,"teacher_disagreement_score":0.01206269,"threshold_uncertainty_score":0.06379431,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2573714925473622,"score_gpt":0.4546496542662193,"score_spread":0.1972781617188571,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}